0001123292-17-000943.txt : 20170516
0001123292-17-000943.hdr.sgml : 20170516
20170516163000
ACCESSION NUMBER: 0001123292-17-000943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170512
FILED AS OF DATE: 20170516
DATE AS OF CHANGE: 20170516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berelowitz Michael
CENTRAL INDEX KEY: 0001493383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 17848953
MAIL ADDRESS:
STREET 1: 415 EAST 37TH STREET
STREET 2: APT 36C
CITY: NEW YORK
STATE: NY
ZIP: 10016
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-05-12
0001588972
Recro Pharma, Inc.
REPH
0001493383
Berelowitz Michael
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Restricted Stock Units
2017-05-12
4
A
0
13274
0
A
Common Stock
13274
13274
D
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date.
/s/ Donna Nichols, attorney-in-fact
2017-05-16